Chain Drug Review - Novartis settles dispute with FTC
Geneva Pharmaceuticals Inc., a unit of Novartis AG, has settled claims by the Federal Trade commission that an agreement it has with Abbott Laboratories over the marketing of a generic drug violated antitrust regulations. The case involves a generic version of Abbott’s Hytrin produced by Geneva.
Related Results
Common prostate drug is ineffective - Hytrin works better - Hytrin vs ProscarMylan receives approval for generic HytrinTorPharm Hytrin ANDA clearedTrust, E-innovation and Leadership in ChangeForeign Banks in United States Since World War II: A Useful Fringe
COPYRIGHT 2000 Racher Press, Inc.
COPYRIGHT 2008 Gale, Cengage Learning
